104756-72-1

Basic information

• Product Name: dimethyl 4-(3,4-dimethoxyphenyl)-1-hydroxy-5,6,7-trimethoxynaphthalene-2,3-dicarboxylate
• Synonyms: 1-(3,4-Dimethoxyphenyl)-2,3-bis(methoxycarbonyl)-4-hydroxy-6,7,8-trimethoxynaphthalene; 2,3-Naphthalenedicarboxylic acid, 4-(3,4-dimethoxyphenyl)-1-hydroxy-5,6,7-trimethoxy-, dimethyl ester
• CAS NO: 104756-72-1
• Molecular Formula: C₂₅H₂₆O₁₀
• Molecular Weight: 486.4679
• Mol File: 104756-72-1.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 592.3°C at 760 mmHg
• Flash Point: 195°C
• Density: 1.269g/cm³
• Vapor Pressure: 1.26E-14mmHg at 25°C
• Refractive Index: 1.58
• CAS DataBase Reference: dimethyl 4-(3,4-dimethoxyphenyl)-1-hydroxy-5,6,7-trimethoxynaphthalene-2,3-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: dimethyl 4-(3,4-dimethoxyphenyl)-1-hydroxy-5,6,7-trimethoxynaphthalene-2,3-dicarboxylate(104756-72-1)
• EPA Substance Registry System: dimethyl 4-(3,4-dimethoxyphenyl)-1-hydroxy-5,6,7-trimethoxynaphthalene-2,3-dicarboxylate(104756-72-1)

Safety Data

• Hazardous Substances Data: 104756-72-1(Hazardous Substances Data)

Upstream product

• 762-42-5 dimethyl acetylenedicarboxylate 
• 104756-71-0 2-(3,4-dimethoxy-α-hydroxybenzyl)-3,4,5-trimethoxybenzaldehyde dimethylacetal 
• 87850-44-0 2-bromo-3,4,5-trimethoxybenzaldehydedimethyl acetal 

Downstream Products

• 130557-65-2 1-(3,4-dimethoxyphenyl)-2,3-bis(methoxycarbonyl)-4-hydroxy-6,7,8-trimethoxynaphthalene sodium salt 

Relevant articles and documents

Arylnaphthalene lignans as novel series of hypolipidemic agents raising high-density lipoprotein level

A series of arylnaphthalene lignans were synthesized and tested for hypolipidemic activity. The most potent compound (4b) (TA-7552) not only reduced serum cholesterol, but also increased high-density lipoproteins cholesterol in rats. The effective dose of

A process for preparing a naphthalene derivative

A novel process for preparing a naphthalene derivative of the formula: wherein R1, R2, R3, R4, R5, R6 and R7 are a lower alkyl group, and an intermediate thereof is disclosed. Said naphthalene derivative (I) and

Naphthalene derivatives, process for their preparation and pharmaceutical compositions containing the same

-